Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Fabian Karl Lohöfer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0370-122X; OpenAlex author ID A5090408246. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2019: 3 papers · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 13

  1. Contrast enhanced CT and MRI interchangeably reflect tumor characteristics in murine pancreatic cancer. Co-author DOI 10.1038/s41598-026-56008-4↗
  2. Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induce… Co-author DOI 10.1007/s00259-025-07195-1↗
  3. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
  4. CT Attenuation of Hepatic Pancreatic Cancer Metastases Correlates with Prognostically Detrimental Metastatic Necrosis. Co-author DOI 10.3390/jcm12237319↗
  5. Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascular… Co-author DOI 10.1007/s00259-022-05930-6↗
  6. High-Resolution, High b-Value Computed Diffusion-Weighted Imaging Improves Detection of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14030470↗
  7. [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13550-021-00808-4↗
  8. Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging. Last author DOI 10.3390/cancers13092069↗
  9. Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm9030724↗
  10. Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters. Co-author DOI 10.3390/jcm9051250↗
  11. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging. Co-author DOI 10.1186/s41747-019-0119-0↗
  12. Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological … First author DOI 10.1371/journal.pone.0208717↗
  13. A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX … Co-author DOI 10.1371/journal.pone.0218642↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rickmer Braren · 12 shared papers, 2019–2026 · strength 1.55
  2. Wilko Weichert · 9 shared papers, 2019–2025 · strength 0.98
  3. Georgios A. Kaissis · 9 shared papers, 2019–2025 · strength 0.98
  4. Sebastian Ziegelmayer · 9 shared papers, 2019–2023 · strength 0.97
  5. Felix N. Harder · 7 shared papers, 2020–2025 · strength 0.86
  6. Jens Thomas Siveke · 6 shared papers, 2019–2025 · strength 0.68
  7. Irina Heid · 3 shared papers, 2022–2026 · strength 0.59
  8. Hana Algül · 4 shared papers, 2019–2025 · strength 0.49
  9. Roland Michael Schmid · 5 shared papers, 2019–2021 · strength 0.46
  10. Friederike Jungmann · 4 shared papers, 2020–2021 · strength 0.41
  11. Helmut Friess · 4 shared papers, 2019–2021 · strength 0.38
  12. Alexander Muckenhuber · 4 shared papers, 2019–2021 · strength 0.38
  13. Lucia Liotta · 2 shared papers, 2022–2025 · strength 0.32
  14. Marija Trajkovic‐Arsic · 2 shared papers, 2022–2025 · strength 0.32
  15. Helmut Frieß · 3 shared papers, 2019–2021 · strength 0.28
  16. Marina Lesina · 1 shared paper, 2026 · strength 0.27
  17. Lea Würfel · 1 shared paper, 2026 · strength 0.27
  18. Stefan Reischl · 1 shared paper, 2023 · strength 0.17
  19. Maximilian Reichert · 1 shared paper, 2021 · strength 0.10
  20. Michael Quante · 1 shared paper, 2021 · strength 0.10
  21. İhsan Ekin Demir · 1 shared paper, 2021 · strength 0.10
  22. Anna Melissa Schlitter · 1 shared paper, 2020 · strength 0.10
  23. Guralp Onur Ceyhan · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.